About the Merkel Cell Cancer Session
Merkel Cell Carcinoma (MCC) is an uncommon but highly malignant skin cancer originating from Merkel cells in the epidermis. Strongly associated with the Merkel cell polyomavirus (MCPyV), present in around 80% of cases, MCC typically affects older adults and those with compromised immune systems. Recent strides in cancer research have led to promising immunotherapies, including checkpoint inhibitors, which enhance the immune system's ability to identify and eradicate cancer cells. Early diagnosis is critical due to MCC's propensity for rapid metastasis, complicating treatment. Research efforts continue to focus on unraveling the molecular underpinnings of MCC, with the goal of developing more effective therapeutic strategies and improving patient survival rates.
Topics Covered in Merkel Cell Cancer
Polyomavirus-Driven Tumors
UV-Driven Tumors
Immunosuppressed Patients
Sentinel Node Biopsy
Adjuvant Radiotherapy
Checkpoint Inhibitors
Related Scientific Sessions at CIOC 2027
Why Attend the Merkel Cell Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Merkel Cell Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Merkel Cell Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Merkel Cell Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Merkel Cell Cancer Conference 2027 — FAQs
What is the Merkel Cell Cancer track at CIOC 2027?
The Merkel Cell Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Merkel Cell Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Merkel Cell Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Merkel Cell Cancer are all welcome — whether presenting or attending.
Can I present my research in the Merkel Cell Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Merkel Cell Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Merkel Cell Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.